The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.

Abstract

The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia. 
DOI: 10.1093/cid/ciw245

Topics

Cite this paper

@article{Franois2016TheSA, title={The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.}, author={Bruno François and Jean Chastre and Philippe Eggiman and P F Laterre and Antoni Torres and Miguel S{\'a}nchez and Mark T. Esser and Brian Bishop and Marc Bonten and Herman Goosens and Hasan S. Jafri}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2016}, volume={63 Suppl 2}, pages={S46-51} }